Clinical Trials Browser

Phase NA × Lapatinib × Breast × Clear all

NCT02158507 2026-01-22

Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

Phase NA Completed

20 enrolled 10 charts

Triple Negative Breast Neoplasms

NCT00555152 2018-04-20

Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ

Phase NA Completed

22 enrolled 9 charts

Carcinoma, Intraductal, Noninfiltrating

NCT00857714 2015-07-08

Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast

Phase NA Terminated

1 enrolled 9 charts

Carcinoma, Intraductal, Noninfiltrating